1. Home
  2. IPHA vs ACR Comparison

IPHA vs ACR Comparison

Compare IPHA & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$2.23

Market Cap

165.3M

Sector

Health Care

ML Signal

N/A

ACR

ACRES Commercial Realty Corp.

N/A

Current Price

$14.85

Market Cap

146.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
IPHA
ACR
Founded
1999
2005
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
165.3M
146.1M
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
IPHA
ACR
Price
$2.23
$14.85
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$5.75
$24.50
AVG Volume (30 Days)
172.7K
31.1K
Earning Date
03-26-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$79,946,000.00
Revenue This Year
$180.36
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$13.83
52 Week High
$2.71
$24.61

Technical Indicators

Market Signals
Indicator
IPHA
ACR
Relative Strength Index (RSI) 57.37 38.98
Support Level $1.68 $13.83
Resistance Level $2.66 $18.56
Average True Range (ATR) 0.15 0.72
MACD 0.01 0.09
Stochastic Oscillator 54.50 54.02

Price Performance

Historical Comparison
IPHA
ACR

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: